title: Bread enriched with microencapsulated tuna oil increases plasma docosahexaenoic acid and total omega-3 fatty acids in humans.
abstract: The aim of this study was to determine the acute and chronic effects of low doses of long chain (LC) n-3 polyunsaturated fatty acids (PUFA) (<100 mg per day) on plasma LC n-3 PUFA levels using a novel delivery form; bread containing microencapsulated tuna oil (MTO). Six omnivores (three men and three women) participated in the acute study, which involved ingesting a prototype MTO bread containing approximately 80 mg of LC n-3 PUFA/four slices. Plasma triacylglycerol fatty acid compositions were measured after an overnight fast and postprandially at 2 and 4 h. In the chronic study, 10 vegetarian subjects (nine men and one woman) consumed MTO bread at six to eight slices/day (comprising 60 mg of LC n-3 PUFA) as the only dietary source of these PUFA for three weeks. Fasting plasma total and phospholipid fatty acid compositions were measured at baseline and endpoint. In the acute study, the proportions of 22:6 n-3 and total n-3 PUFA in plasma triacylglycerol were significantly increased (P < 0.05). In the chronic study, the proportions of 20:5 n-3, 22:5 n-3, 22:6 n-3, total n-3 PUFA in plasma, and 22:6 n-3 and total n-3 PUFA in plasma phospholipid fractions were significantly increased (P < 0.05) at the endpoint compared with the baseline. This study showed that a low dose of LC n-3 PUFA, consumed as MTO-enriched bread, was bioavailable, as measured by an increase in LC n-3 PUFA levels in the plasma of human subjects.
authors.affiliation: Department of Food Science, RMIT University, Melbourne, Victoria, Australia.
authors.forename: Yolande L
authors.initials: YL
authors.lastname: Yep
authors.forename: Duo
authors.initials: D
authors.lastname: Li
authors.forename: Neil J
authors.initials: NJ
authors.lastname: Mann
authors.forename: Ortwin
authors.initials: O
authors.lastname: Bode
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Sinclair
mesh_terms: D000328:Adult; D000818:Animals; D001682:Biological Availability; D001939:Bread; D004281:Docosahexaenoic Acids / Q000097:blood* / Q000493:pharmacokinetics; D004339:Drug Compounding; D005215:Fasting; D015525:Fatty Acids, Omega-3 / Q000097:blood* / Q000493:pharmacokinetics; D005260:Female; D005395:Fish Oils / Q000008:administration & dosage*; D005527:Food, Fortified; D006801:Humans; D008297:Male; D008875:Middle Aged; D019518:Postprandial Period; D014280:Triglycerides / Q000097:blood / Q000378:metabolism; D014413:Tuna
chemical_list: D015525:Fatty Acids, Omega-3; D005395:Fish Oils; D014280:Triglycerides; D004281:Docosahexaenoic Acids